First Time Loading...

Forma Therapeutics Holdings Inc
NASDAQ:FMTX

Watchlist Manager
Forma Therapeutics Holdings Inc Logo
Forma Therapeutics Holdings Inc
NASDAQ:FMTX
Watchlist
Price: 20.01 USD Market Closed
Updated: May 20, 2024

Forma Therapeutics Holdings Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Forma Therapeutics Holdings Inc
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Forma Therapeutics Holdings Inc
NASDAQ:FMTX
Accounts Payable
$4.1m
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Payable
$31.3B
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
$622m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$1.6B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$351.4m
CAGR 3-Years
40%
CAGR 5-Years
34%
CAGR 10-Years
22%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$671.3m
CAGR 3-Years
7%
CAGR 5-Years
23%
CAGR 10-Years
35%

See Also

What is Forma Therapeutics Holdings Inc's Accounts Payable?
Accounts Payable
4.1m USD

Based on the financial report for Dec 31, 2021, Forma Therapeutics Holdings Inc's Accounts Payable amounts to 4.1m USD.

What is Forma Therapeutics Holdings Inc's Accounts Payable growth rate?
Accounts Payable CAGR 3Y
-13%

Over the last year, the Accounts Payable growth was -4%. The average annual Accounts Payable growth rates for Forma Therapeutics Holdings Inc have been -13% over the past three years .